Ozempic Constipation: Why It Happens and When to Get Help

Ozempic constipation is a common, usually manageable side effect. In the U.S. prescribing information, 3.1% to 5% of adults with type 2 diabetes taking Ozempic reported constipation, versus 1.5% on placebo, and the rate was much higher with the weight-management version of the same molecule: 24% on Wegovy versus 11% on placebo. GLP-1 medicines slow how fast the stomach empties, and people usually eat and drink less, so stools can become harder and less frequent. Fluids, fiber and movement help many people. The labels also list rare reports of ileus and bowel obstruction, so severe belly pain, vomiting or being unable to pass gas needs prompt medical care.

Peptide Labs does not sell Ozempic, Wegovy, Mounjaro, Zepbound or any prescription drug. This article summarizes FDA labels and published research. For the full list of effects, see our guide to side effects across the GLP-1 class.

How common is GLP-1 constipation? Label rates by drug

GLP-1 constipation shows up in every current U.S. label in this class. The table lists the constipation rows from each label’s placebo-controlled trials. Ranges span the maintenance strengths, and the trials enrolled different people for different lengths of time, so read the numbers as context rather than a ranking.

The pattern is consistent: products used for weight management, at higher strengths and in people without diabetes, report more constipation than the diabetes versions. Placebo groups also report some constipation, which is a reminder that diet changes alone can slow the bowels.

Constipation on Wegovy: how long it tends to last

The most detailed timing data come from a pooled analysis of the STEP 1 to 3 trials, published in Diabetes, Obesity and Metabolism in 2022. It covered 2,117 adults taking semaglutide for weight management and 1,262 on placebo for 68 weeks. Constipation was reported by 24.2% versus 11.1%. A constipation episode lasted a median of 47 days on semaglutide and 35 days on placebo, and the share of people with constipation leveled off around week 10. By comparison, a typical nausea episode lasted 8 days. Nearly all digestive side effects (98.1%) were mild to moderate. Novo Nordisk funded the analysis and several authors are company employees.

So constipation on Wegovy behaves differently from nausea: it starts a little later, lasts longer and fades more slowly. That is a reason to set up good habits early rather than waiting.

Why GLP-1 medicines slow the bowels

The labels state that semaglutide and tirzepatide delay gastric emptying, meaning food leaves the stomach more slowly. A 2022 expert consensus from a Spanish multidisciplinary panel, published in the Journal of Clinical Medicine, adds a practical cause: feeling full makes people drink less water, which may predispose them to constipation. Eating smaller portions also means less fiber. Most of the panel’s authors reported fees from GLP-1 manufacturers.

Other factors can stack on top. NIDDK lists medicines that commonly cause constipation, including iron supplements, antacids with aluminum or calcium, narcotic pain medicines, some depression medicines, diuretics and calcium channel blockers. If you take any of these, mention it to your pharmacist.

What helps with Ozempic constipation

The steps below come from NIDDK’s general constipation guidance and the expert panel’s advice for people on GLP-1 medicines. They are general habits, not a substitute for your prescriber’s advice.

• Drink enough fluid. NIDDK says water and other liquids help fiber work better, and the Ozempic Medication Guide reminds people to drink fluids to reduce the chance of dehydration. Sip through the day if large drinks feel uncomfortable.
• Add fiber gradually. NIDDK puts adult needs at 22 to 34 grams a day depending on age and sex, and advises adding fiber a little at a time. Vegetables, fruit with skin, beans and whole grains count. Our guide to daily fiber needs explains the targets.
• Keep moving. NIDDK lists physical activity as a first step, and the panel advises more mobility for people on GLP-1 therapy.
• Use the morning window. NIDDK notes that trying for a bowel movement 15 to 45 minutes after breakfast may help, because eating prompts the colon to move stool.
• Watch low-fiber convenience foods. Chips, fast food and processed meals add little fiber. Ideas for small, fiber-rich meals are in our eating guide for GLP-1 medicines.

OTC laxatives to discuss with a pharmacist

If habits are not enough, NIDDK describes five types of over-the-counter laxatives. The expert panel mentions fiber and stool softeners for people on GLP-1 therapy. A pharmacist can check how each option fits your other medicines, which matters because GLP-1 drugs can change how quickly oral medicines are absorbed.

• Fiber supplements such as psyllium (Metamucil) or methylcellulose (Citrucel) add bulk and need plenty of fluid. See how fiber helps with constipation and how fiber compares with Miralax.
• Osmotic agents such as polyethylene glycol (Miralax) or milk of magnesia draw water into the stool. Our magnesium oxide guide covers magnesium laxatives and who should be careful with them.
• Stool softeners such as docusate (Colace).
• Lubricants such as mineral oil.
• Stimulant laxatives, which NIDDK says to use only if constipation is severe or other options have not worked.

Probiotics are sometimes suggested too; the evidence is mixed and strain-specific, as our guide to probiotics and constipation explains. NIDDK also advises not to change or stop any medicine without talking with a health care professional, so tell your prescriber rather than skipping your GLP-1 medicine. The panel notes prescribers may keep a patient at a lower strength for longer when digestive symptoms persist.

Mounjaro constipation and other GLP-1 drugs

Mounjaro constipation appeared in 6% to 7% of people with type 2 diabetes in its label trials versus 1% on placebo, while Zepbound, the same tirzepatide molecule for weight management, reported 11% to 17% versus 5%. Foundayo, a daily tablet for weight management, listed constipation as its second most common side effect. The Zepbound label says most people who stopped it because of side effects did so in the first few months, mainly for digestive reasons. More detail is in our guides to tirzepatide side effects, Zepbound and Wegovy.

Red flags: when constipation needs urgent care

Every label in the table lists postmarketing reports of ileus (the bowel stops moving), intestinal obstruction and severe constipation including fecal impaction. These reports are voluntary, so their true frequency is unknown, but they are why worsening symptoms should not be ignored. NIDDK and the Medication Guides point to these warning signs:

• No bowel movement for several days together with a swollen belly or being unable to pass gas.
• Constant or severe abdominal pain, especially pain that will not go away or spreads to the back, which the Medication Guide links to pancreatitis.
• Vomiting, particularly if you cannot keep fluids down.
• Blood in the stool or bleeding from the rectum.
• Fever, or pain in the upper stomach with yellowing of the skin or eyes, which can signal gallbladder problems.
• Losing weight without trying, beyond what the medicine is expected to do, or new lower back pain with constipation (both on NIDDK’s list).

If any of these happen, contact your prescriber the same day or seek urgent care. The labels also say these medicines are not recommended for people with severe gastroparesis. For nausea, which usually comes earlier, see our guide to Ozempic nausea.

Frequently Asked Questions

Peptide Labs does not sell GLP-1 medicines or any prescription drug. This article is general information, not medical advice. Read the Medication Guide that comes with a prescription, and ask a pharmacist or prescriber how this information applies to you.

Last reviewed October 2026.

Related guides: GLP-1 Side Effects: What Every GLP-1 Drug Label Warns About, Fiber for Constipation: What the Evidence Says, How Long It Takes and Natural Laxative Foods, Metamucil vs MiraLAX: Fiber Laxative vs Osmotic Laxative, and Where Stool Softeners Fit, Ozempic Diarrhea: How Common It Is and When to Call.